BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27671064)

  • 21. N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis.
    Sy SK; de Kock L; Diacon AH; Werely CJ; Xia H; Rosenkranz B; van der Merwe L; Donald PR
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4129-38. PubMed ID: 25963985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
    Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on
    Šudomová M; Shariati MA; Echeverría J; Berindan-Neagoe I; Nabavi SM; Hassan STS
    Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31739453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice.
    Sugamori KS; Brenneman D; Grant DM
    Drug Metab Dispos; 2011 May; 39(5):882-90. PubMed ID: 21317369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.
    Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY
    Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phylogenetic and Structural Significance of Dihydrofolate Synthase (folC) Mutations in Drug-Resistant Mycobacterium tuberculosis.
    Cheng VW; Leung KS; Kwok JS; Leung RK; Yang KY; Chan RC; Kam KM; Tsui SK
    Microb Drug Resist; 2016 Oct; 22(7):545-551. PubMed ID: 27082669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
    Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
    J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid.
    Fivian-Hughes AS; Houghton J; Davis EO
    Microbiology (Reading); 2012 Feb; 158(Pt 2):308-318. PubMed ID: 22034487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High throughput screening of 7-methylpicene-1,2-diol as arylamine N-acetyltransferase (NAT) inhibitor to establish a isoniazid supplement in anti-tubercular therapy.
    Chowdhury A; Paul P; Choudhury MD
    Comb Chem High Throughput Screen; 2013 Nov; 16(9):721-5. PubMed ID: 23701008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Mycobacterium tuberculosis with isoniazid: a computational study on a new possible mechanism of resistance.
    Ramos RM; Perez JM; Baptista LA; de Amorim HL
    J Mol Model; 2012 Sep; 18(9):4013-24. PubMed ID: 22460521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combination screening to identify enhancers of para-aminosalicylic acid against Mycobacterium tuberculosis.
    Heo J; Koh D; Woo M; Kwon D; de Almeida Falcão VC; Wood C; Lee H; Kim K; Choi I; Jang J; Brodin P; Shum D; Delorme V
    Sci Rep; 2022 Apr; 12(1):5635. PubMed ID: 35379873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence and structural characterization of tbnat gene in isoniazid-resistant Mycobacterium tuberculosis: identification of new mutations.
    Coelho MB; Costa ER; Vasconcellos SE; Linck N; Ramos RM; Amorim HL; Suffys PN; Santos AR; Silva PE; Ramos DF; Silva MS; Rossetti ML
    Mutat Res; 2011 Jul; 712(1-2):33-9. PubMed ID: 21514309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a highly biocompatible antituberculosis nanodelivery formulation based on para-aminosalicylic acid-zinc layered hydroxide nanocomposites.
    Saifullah B; Arulselvan P; El Zowalaty ME; Fakurazi S; Webster TJ; Geilich B; Hussein MZ
    ScientificWorldJournal; 2014; 2014():401460. PubMed ID: 25050392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
    Abuhammad AM; Lowe ED; Fullam E; Noble M; Garman EF; Sim E
    Protein Cell; 2010 Apr; 1(4):384-392. PubMed ID: 21203950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between mutations in a
    Zeng R; He L; Zhang B; Hu Y; Yu J; Yang S; Gu J; Wu Z; Deng J
    Emerg Microbes Infect; 2023 Dec; 12(2):2276339. PubMed ID: 38029724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimycobacterial, antimicrobial, and biocompatibility properties of para-aminosalicylic acid with zinc layered hydroxide and Zn/Al layered double hydroxide nanocomposites.
    Saifullah B; El Zowalaty ME; Arulselvan P; Fakurazi S; Webster TJ; Geilich BM; Hussein MZ
    Drug Des Devel Ther; 2014; 8():1029-36. PubMed ID: 25114509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
    Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
    Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temperature stability of proteins essential for the intracellular survival of Mycobacterium tuberculosis.
    Lack NA; Kawamura A; Fullam E; Laurieri N; Beard S; Russell AJ; Evangelopoulos D; Westwood I; Sim E
    Biochem J; 2009 Mar; 418(2):369-78. PubMed ID: 19014350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knocking out salicylate biosynthesis genes in Mycobacterium smegmatis induces hypersensitivity to p-aminosalicylate (PAS).
    Nagachar N; Ratledge C
    FEMS Microbiol Lett; 2010 Oct; 311(2):193-9. PubMed ID: 20735479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.